Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Record SOFR options volume and open interest CHICAGO , Feb. 2, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its January 2023 market statistics, showing an average daily volume (ADV) of 21.7 million contracts during the month. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports January 2023 Monthly Market Statistics

Activision Blizzard

Colgate-Palmolive

Centene

CVS Health

Keurig Dr Pepper Inc

Paychex

Republic Services

Sysco

2022 has been a bad year for the equity market, with inflation and interest rates being the primary factors weighing on stocks throughout 2022.

10 Large Cap Stocks Trading Close to 52-Week Lows

Financial data exchanges like CME Group Inc. have ballooned in value over the past 20 years. Future regulation may prove costly to the financial derivatives industry.

CME Group: Valuation Issues Persist

CHICAGO , Jan. 31, 2023 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced it will expand its suite of weekly options expiries for its E-mini Russell 2000 futures with the launch of Tuesday and Thursday weekly options on February 27, pending regulatory review. These new weekly options contracts will complement the existing Monday, Wednesday and Friday Weeklies, as well as End-of-Month and Quarterly options on Russell 2000 futures.

CME Group to Launch E-mini Russell 2000 Tuesday and Thursday Weekly Options on February 27

Blackrock Inc

Cummins

Honeywell

Intercontinental Exchange

Iron Mountain

Illinois Tool Works

Coca-Cola

Leggett & Platt

Medtronic

Altria

Realty Income Corp

Omega Healthcare Investors

S&P Global

AT&T

Thermo Fisher Scientific

Tractor Supply

Twilio

Unilever

Visa

Yum China Hlds

Analyzing my real-life portfolio's dividend growth for 2022. Dividend growth pulled back some compared to 2021; however, it was still a strong year of dividend growth.

Dividend Growth Checkup - 2022

CHICAGO , Jan. 19, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that open interest in Copper Options (HX) has reached multiple, back-to-back records, reaching 137,574 contracts on January 18, 2023. Average daily volume (ADV) across the company's Copper Futures and Options complex is at 131,466 contracts month-to-date, up 42% from full-year 2022 ADV.

CME Group Announces Record Copper Options Open Interest As Participation Grows Across Base Metals

CHICAGO , Jan. 17, 2023 /PRNewswire/ -- CME Group ,  the world's leading derivatives marketplace, today announced it will expand its suite of weekly options expiries for its Micro E-mini Nasdaq-100 and S&P 500 futures with the launch of Monday, Tuesday, Wednesday, and Thursday Weekly options on February 13, pending regulatory review. These new weekly options contracts will complement the existing Friday Weeklies, End-of-Month and Quarterly options on Micro E-mini Nasdaq-100 and S&P 500 futures.

CME Group to Launch Micro E-mini Nasdaq-100 and S&P 500 Monday, Tuesday, Wednesday and Thursday Weekly Options on February 13

Record 7,558,467 SOFR-based contracts traded, with record open interest of 35,698,298 contracts CHICAGO , Jan. 13, 2023 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced new milestones in the growth of its SOFR derivatives contracts, with a single-day record of 7,558,467 SOFR futures and options traded and record open interest (OI) of 35,698,298 contracts on January 12. Individually, SOFR futures reached a record of 4,513,725 contracts traded on the same day.

CME Group SOFR Futures and Options Trade a Record 7.56 Million Contracts on January 12

AbbVie

Caterpillar

Canadian Pacific Kansas City Limited

Chevron

Deere & Company

Danaher

Duke Energy

Extra Space Storage

Huntington Bancshares

Home Depot

Huntington Ingalls Industries

L3Harris

Lockheed Martin

Nasdaq

Northrop Grumman

Norfolk Southern

PepsiCo

Public Storage

Raytheon Technologies

Schwab US Dividend Equity ETF

Union Pacific

Vanguard Dividend Appreciation ETF

Valero Energy

Vanguard High Dividend Yield ETF

As requested by many, I decided to dedicate an article to my personal dividend growth portfolio, consisting of more than 90% of my net worth. I start by explaining my strategy and approach, followed by a discussion of the benefits that come with dividend (growth) investment strategies.

My 6-Figure Market-Beating Dividend Growth Portfolio

LONDON and SINGAPORE , Jan. 11, 2023 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today announced that it achieved record international average daily volume (ADV) of 6.3 million contracts in 2022, up 15% from 2021. This record, reflecting all trading done outside the United States, was driven largely by growth in Equity Index and Foreign Exchange products, up 26% and 22% respectively.

CME Group Achieves Record International Average Daily Volume of 6.3 Million Contracts in 2022, Up 15% from 2021

Airbnb

Biohaven Pharmaceutical Hld

Cowen

Evo Payments

Garmin

Liberty Media Corp-Liberty SiriusXM

Mastercard

VMware

Paul Tudor Jones is one of the most respected names in the hedge fund industry.

These Are the Top 10 Holdings of Paul Tudor Jones

Adobe

Autodesk

Amazon

Bank of America

Comcast

Salesforce

Fortinet

Alphabet

Lam Research

Masco

Microchip Technology

MarketAxess Holdings

Monolithic Power Systems

ServiceNow

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.

U.S. Wide-Moat Stocks On Sale: The January 2023 Heat Map

News for CME Group Stock (CME)